首页 > 最新文献

Biomedical Instrumentation and Technology最新文献

英文 中文
Potential Induced Radioactivity in Materials Processed with X-ray Energy Above 5 MeV. 用5兆电子伏特以上的x射线处理材料的电位诱导放射性。
Q4 Medicine Pub Date : 2021-03-01 DOI: 10.2345/0899-8205-55.s3.17
Hervé Michel, Thomas Kroc, Brian J McEvoy, Deepak Patil, Pierre Reppert, Mark A Smith

Section 5.1.2 of ANSI/AAMI/ISO 11137-1 states that "the potential for induced radioactivity in product shall be assessed." This article describes how compliance with this requirement may be achieved using qualified test methods. Materials of consideration are conceptually discussed, and results of testing conducted on products processed with a 7.5-MeV X-ray irradiation process are provided. As X-ray becomes more widely used in healthcare sterilization, having standard assessment protocols for activation coupled with a shared database of material test results will benefit manufacturers seeking to utilize this innovative technology.

ANSI/AAMI/ISO 11137-1第5.1.2节规定“应评估产品中诱发放射性的可能性”。本文描述了如何使用合格的测试方法来满足这一要求。对考虑的材料进行了概念性讨论,并提供了对7.5 mev x射线辐照工艺处理的产品进行的测试结果。随着x射线在医疗保健灭菌中的应用越来越广泛,拥有标准的激活评估方案以及共享的材料测试结果数据库将有利于寻求利用这一创新技术的制造商。
{"title":"Potential Induced Radioactivity in Materials Processed with X-ray Energy Above 5 MeV.","authors":"Hervé Michel,&nbsp;Thomas Kroc,&nbsp;Brian J McEvoy,&nbsp;Deepak Patil,&nbsp;Pierre Reppert,&nbsp;Mark A Smith","doi":"10.2345/0899-8205-55.s3.17","DOIUrl":"https://doi.org/10.2345/0899-8205-55.s3.17","url":null,"abstract":"<p><p>Section 5.1.2 of ANSI/AAMI/ISO 11137-1 states that \"the potential for induced radioactivity in product shall be assessed.\" This article describes how compliance with this requirement may be achieved using qualified test methods. Materials of consideration are conceptually discussed, and results of testing conducted on products processed with a 7.5-MeV X-ray irradiation process are provided. As X-ray becomes more widely used in healthcare sterilization, having standard assessment protocols for activation coupled with a shared database of material test results will benefit manufacturers seeking to utilize this innovative technology.</p>","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"55 s3","pages":"17-26"},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655703/pdf/i0899-8205-55-s3-17.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39253190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Lessons from the Glass Cockpit: Innovation in Alarm Systems to Support Cognitive Work. 玻璃座舱的教训:支持认知工作的报警系统创新。
Q4 Medicine Pub Date : 2021-01-01 DOI: 10.2345/0899-8205-55.1.29
Randall J Mumaw, Emilie M Roth, Emily S Patterson

Nurses working in the hospital setting increasingly have become overburdened by managing alarms that, in many cases, provide low information value regarding patient health. The current trend, aided by disposable, wearable technologies, is to promote patient monitoring that does not require entering a patient's room. The development of telemetry alarms and middleware escalation devices adds to the continued growth of auditory, visual, and haptic alarms to the hospital environment but can fail to provide a more complete understanding of patient health. As we begin to innovate to both address alarm overload and improve patient management, perhaps using fundamentally different integration architectures, lessons from the aviation flight deck are worth considering. Commercial jet transport systems and their alarms have evolved slowly over many decades and have developed integration methods that account for operational context, provide multiple response protocol levels, and present a more integrated view of the airplane system state. We articulate three alarm system objectives: (1) supporting hazard management, (2) establishing context, and (3) supporting alarm prioritization. More generally, we present the case that alarm design in aviation can spur directions for innovation for telemetry monitoring systems in hospitals.

在医院工作的护士越来越多地因管理警报而负担过重,在许多情况下,这些警报提供的有关患者健康的信息价值很低。在一次性可穿戴技术的帮助下,目前的趋势是促进不需要进入病人房间的病人监护。遥测警报和中间件升级设备的发展增加了对医院环境的听觉、视觉和触觉警报的持续增长,但可能无法提供对患者健康更全面的了解。当我们开始创新以解决警报过载和改善患者管理时,可能会使用根本不同的集成架构,从航空驾驶舱吸取的教训值得考虑。商用喷气式飞机运输系统及其警报系统在过去几十年里发展缓慢,并且已经开发出了考虑操作环境的集成方法,提供了多个响应协议级别,并提供了一个更综合的飞机系统状态视图。我们阐明了三个报警系统目标:(1)支持危害管理,(2)建立上下文,(3)支持报警优先级。更一般地说,我们提出了航空报警设计可以刺激医院遥测监测系统创新方向的案例。
{"title":"Lessons from the Glass Cockpit: Innovation in Alarm Systems to Support Cognitive Work.","authors":"Randall J Mumaw,&nbsp;Emilie M Roth,&nbsp;Emily S Patterson","doi":"10.2345/0899-8205-55.1.29","DOIUrl":"https://doi.org/10.2345/0899-8205-55.1.29","url":null,"abstract":"<p><p>Nurses working in the hospital setting increasingly have become overburdened by managing alarms that, in many cases, provide low information value regarding patient health. The current trend, aided by disposable, wearable technologies, is to promote patient monitoring that does not require entering a patient's room. The development of telemetry alarms and middleware escalation devices adds to the continued growth of auditory, visual, and haptic alarms to the hospital environment but can fail to provide a more complete understanding of patient health. As we begin to innovate to both address alarm overload and improve patient management, perhaps using fundamentally different integration architectures, lessons from the aviation flight deck are worth considering. Commercial jet transport systems and their alarms have evolved slowly over many decades and have developed integration methods that account for operational context, provide multiple response protocol levels, and present a more integrated view of the airplane system state. We articulate three alarm system objectives: (1) supporting hazard management, (2) establishing context, and (3) supporting alarm prioritization. More generally, we present the case that alarm design in aviation can spur directions for innovation for telemetry monitoring systems in hospitals.</p>","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"55 1","pages":"29-40"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641425/pdf/i0899-8205-55-1-29.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25436835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Overview of a Robust Human Factors Engineering Process. 稳健的人因工程过程概述。
Q4 Medicine Pub Date : 2021-01-01 DOI: 10.2345/0899-8205-55.1.16
Tressa Daniels, Tim Goldsmith, Anindya Basu
All medical device companies perform human factors engineering (HFE) in some capacity. Human factors validation often is required for a medical product to reach market. The type of human factors validation that each device undergoes can be based on the medical device regulatory risk classification, severity of harm associated with the use of the device, or product complexity. Some companies treat the human factors validation process as a check box at the end of product development rather than using the HFE process throughout the product life cycle, which can lead to costly validation tests that generate a multitude of usability issues that need to be fixed, thereby delaying timelines and launch dates and harming a company’s bottom line. Companies that incorporate a robust HFE process into the entire product life cycle find that they have increased product safety and decreased development time. It also results in a competitive advantage in the marketplace. This article provides an overview and introduction to what a robust HFE process looks like.
{"title":"Overview of a Robust Human Factors Engineering Process.","authors":"Tressa Daniels,&nbsp;Tim Goldsmith,&nbsp;Anindya Basu","doi":"10.2345/0899-8205-55.1.16","DOIUrl":"https://doi.org/10.2345/0899-8205-55.1.16","url":null,"abstract":"All medical device companies perform human factors engineering (HFE) in some capacity. Human factors validation often is required for a medical product to reach market. The type of human factors validation that each device undergoes can be based on the medical device regulatory risk classification, severity of harm associated with the use of the device, or product complexity. Some companies treat the human factors validation process as a check box at the end of product development rather than using the HFE process throughout the product life cycle, which can lead to costly validation tests that generate a multitude of usability issues that need to be fixed, thereby delaying timelines and launch dates and harming a company’s bottom line. Companies that incorporate a robust HFE process into the entire product life cycle find that they have increased product safety and decreased development time. It also results in a competitive advantage in the marketplace. This article provides an overview and introduction to what a robust HFE process looks like.","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"55 1","pages":"16-20"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641423/pdf/i0899-8205-55-1-16.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25335623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hey You, Get On the Cloud: Safe and Compliant Use of Cloud Computing with Medical Devices. 嘿,你,上云:安全合规地使用云计算与医疗设备。
Q4 Medicine Pub Date : 2021-01-01 DOI: 10.2345/0899-8205-55.1.1
Clay Anselmo, Mike Attili, Randy Horton, Bernhard Kappe, Josh Schulman, Pat Baird
Numerous well-established principles, standards, and best practices serve as a robust framework for hardware-based medical device development, manufacturing, and maintenance, with the goal of ensuring ongoing safety and effectiveness. These range from broad frameworks (e.g., the Food and Drug Administration’s [FDA’s] Total Product Life Cycle) to specific standards, guidelines, and broadly accepted best practices (e.g., the ubiquitous ISO 13485 and corresponding implementation in the FDA Quality System Regulation requirements [21 CFR 820]). Because of the origin of medical devices in hardware, sections of these standards/regulations were clearly written with hardware in mind. The advent of devices that are exclusively software (Software as a Medical Device [SaMD]) created challenges for the medical device industry, ranging from development methodologies to manufacturing and postmarket maintenance and upgrades. These continue to be addressed via the adaptation of existing medical device frameworks for the SaMD life cycle in the creation of new standards and best practices (e.g., developing practices outlined in IEC 62304 and the quality principles promulgated by the International Medical Devices Regulator Forum [IMDRF]). Most recently, the execution of software has increasingly moved away from local storage and processing toward a cloud-based paradigm. This presents new challenges and opportunities throughout the development and product life cycle. However, frameworks for a cloud-based life cycle have not been fully defined. This article seeks to address the current lack of a consensus framework/guidance/ initial best practices and regulatory uncertainty around the use of cloud technology as a component in the operation of regulated medical devices. The authors believe that this issue can best be addressed by creating a well-understood and repeatable pathway, which this article can help kickstart, followed by progression to a consensus report. After that, if there is collective value for the ecosystem to take this pathway further, this work could evolve into an AAMI Technical Information Report (TIR) or approved standard. The objective of developing new standards or guidance is to provide the industry with a clearly marked path to move forward to a “medical device cloud framework” that takes into account the following: • Use of cloud technology in a sustained, compliant manner • A large collection of available cloud technology currently exists that is well established, reliable, and being used in the regulated industry • The existence of established, highly competent cloud technology providers for cloud computing • Certain aspects of cloud technology actually can be less risky compared with traditional medical device computing models This article will discuss the following topics: • History of the cloud • The National Institute of Standards and Technology’s (NIST’s) definition of the cloud • Current obstacles and compliance issues related to cloud
{"title":"Hey You, Get On the Cloud: Safe and Compliant Use of Cloud Computing with Medical Devices.","authors":"Clay Anselmo,&nbsp;Mike Attili,&nbsp;Randy Horton,&nbsp;Bernhard Kappe,&nbsp;Josh Schulman,&nbsp;Pat Baird","doi":"10.2345/0899-8205-55.1.1","DOIUrl":"https://doi.org/10.2345/0899-8205-55.1.1","url":null,"abstract":"Numerous well-established principles, standards, and best practices serve as a robust framework for hardware-based medical device development, manufacturing, and maintenance, with the goal of ensuring ongoing safety and effectiveness. These range from broad frameworks (e.g., the Food and Drug Administration’s [FDA’s] Total Product Life Cycle) to specific standards, guidelines, and broadly accepted best practices (e.g., the ubiquitous ISO 13485 and corresponding implementation in the FDA Quality System Regulation requirements [21 CFR 820]). Because of the origin of medical devices in hardware, sections of these standards/regulations were clearly written with hardware in mind. The advent of devices that are exclusively software (Software as a Medical Device [SaMD]) created challenges for the medical device industry, ranging from development methodologies to manufacturing and postmarket maintenance and upgrades. These continue to be addressed via the adaptation of existing medical device frameworks for the SaMD life cycle in the creation of new standards and best practices (e.g., developing practices outlined in IEC 62304 and the quality principles promulgated by the International Medical Devices Regulator Forum [IMDRF]). Most recently, the execution of software has increasingly moved away from local storage and processing toward a cloud-based paradigm. This presents new challenges and opportunities throughout the development and product life cycle. However, frameworks for a cloud-based life cycle have not been fully defined. This article seeks to address the current lack of a consensus framework/guidance/ initial best practices and regulatory uncertainty around the use of cloud technology as a component in the operation of regulated medical devices. The authors believe that this issue can best be addressed by creating a well-understood and repeatable pathway, which this article can help kickstart, followed by progression to a consensus report. After that, if there is collective value for the ecosystem to take this pathway further, this work could evolve into an AAMI Technical Information Report (TIR) or approved standard. The objective of developing new standards or guidance is to provide the industry with a clearly marked path to move forward to a “medical device cloud framework” that takes into account the following: • Use of cloud technology in a sustained, compliant manner • A large collection of available cloud technology currently exists that is well established, reliable, and being used in the regulated industry • The existence of established, highly competent cloud technology providers for cloud computing • Certain aspects of cloud technology actually can be less risky compared with traditional medical device computing models This article will discuss the following topics: • History of the cloud • The National Institute of Standards and Technology’s (NIST’s) definition of the cloud • Current obstacles and compliance issues related to cloud ","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"55 1","pages":"1-15"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641424/pdf/i0899-8205-55-1-1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38839068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nurse and Pharmacist Knowledge of Intravenous Smart Pump System Setup Requirements. 护士和药剂师了解静脉注射智能泵系统设置要求。
Q4 Medicine Pub Date : 2021-01-01 DOI: 10.2345/0890-8205-55.1.51
K. Giuliano, Jeannine W C Blake
OBJECTIVEThe primary purpose of this research was to describe nurse and pharmacist knowledge of setup requirements for intravenous (IV) smart pumps that require head height differentials for accurate fluid flow.METHODSA secondary analysis of anonymous electronic survey data using a database of prerecruited clinicians was conducted. A survey was sent by email to 173 pharmacists and 960 nurses. The response rate for pharmacists was 58% (100 of 173), and the response rate for nurses was 52% (500 of 960). After removing respondents who did not provide direct care and who did not use a head height differential IV infusion system, the final sample for analysis was 186 nurses and 25 pharmacists.RESULTSOverall, less than one-half of respondents (40%) were aware that manufacturer guidelines for positioning the primary infusion bag relative to the infusion pump were available. Slightly more (49.5%) were aware of the required head height differentials for secondary infusion. Only five respondents selected the correct primary head height, eight respondents selected the correct secondary head height, and one respondent selected both the correct primary and secondary head heights.CONCLUSIONThe results of this study identify a substantial lack of knowledge among frontline clinicians regarding manufacturer recommendations for accurate IV administration of primary and secondary infusions for head height differential infusion systems. Both increased clinician education and innovative technology solutions are needed to improve IV smart pump safety and usability.
目的本研究的主要目的是描述护士和药剂师对静脉注射(IV)智能泵的设置要求的了解,这些智能泵需要头部高度差才能实现准确的流体流动。方法使用预先注册的临床医生数据库对匿名电子调查数据进行二次分析。一项调查通过电子邮件发送给173名药剂师和960名护士。药剂师的应答率为58%(173人中有100人),护士的应答率是52%(960人中有500人)。在排除了没有提供直接护理和没有使用头部高度差静脉输液系统的受访者后,分析的最终样本是186名护士和25名药剂师。结果总体而言,不到一半的受访者(40%)知道制造商关于将主输液袋相对于输液泵定位的指南是可用的。略多于(49.5%)的人知道二次输液所需的头部高度差异。只有五名受访者选择了正确的主要头部高度,八名受访者选择正确的次要头部高度,一名受访者同时选择正确的主要和次要头部高度。结论这项研究的结果表明,一线临床医生对制造商关于头部高度差输液系统一次和二次输液准确静脉注射的建议缺乏了解。需要加强临床医生教育和创新技术解决方案,以提高IV智能泵的安全性和可用性。
{"title":"Nurse and Pharmacist Knowledge of Intravenous Smart Pump System Setup Requirements.","authors":"K. Giuliano, Jeannine W C Blake","doi":"10.2345/0890-8205-55.1.51","DOIUrl":"https://doi.org/10.2345/0890-8205-55.1.51","url":null,"abstract":"OBJECTIVE\u0000The primary purpose of this research was to describe nurse and pharmacist knowledge of setup requirements for intravenous (IV) smart pumps that require head height differentials for accurate fluid flow.\u0000\u0000\u0000METHODS\u0000A secondary analysis of anonymous electronic survey data using a database of prerecruited clinicians was conducted. A survey was sent by email to 173 pharmacists and 960 nurses. The response rate for pharmacists was 58% (100 of 173), and the response rate for nurses was 52% (500 of 960). After removing respondents who did not provide direct care and who did not use a head height differential IV infusion system, the final sample for analysis was 186 nurses and 25 pharmacists.\u0000\u0000\u0000RESULTS\u0000Overall, less than one-half of respondents (40%) were aware that manufacturer guidelines for positioning the primary infusion bag relative to the infusion pump were available. Slightly more (49.5%) were aware of the required head height differentials for secondary infusion. Only five respondents selected the correct primary head height, eight respondents selected the correct secondary head height, and one respondent selected both the correct primary and secondary head heights.\u0000\u0000\u0000CONCLUSION\u0000The results of this study identify a substantial lack of knowledge among frontline clinicians regarding manufacturer recommendations for accurate IV administration of primary and secondary infusions for head height differential infusion systems. Both increased clinician education and innovative technology solutions are needed to improve IV smart pump safety and usability.","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"55 1 1","pages":"51-58"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45528697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Balancing Patient Safety, Clinical Efficacy, and Cybersecurity with Clinician Partners. 与临床医生合作伙伴平衡患者安全、临床疗效和网络安全。
Q4 Medicine Pub Date : 2021-01-01 DOI: 10.2345/0899-8205-55.1.21
Joseph Schneider, Axel Wirth
Where We Stand Today Cybersecurity events affecting healthcare organizations are in the news with increasing frequency, indicating their growing impact and expanse. We have seen incidents ranging from breaches affecting millions of patient records to attacks shutting down hospitals across the country, with at least one of them tragically contributing to the death of a patient. Most recently, the Cybersecurity and Infrastructure Security Agency, Federal Bureau of Investigation, and Department of Health & Human Services (HHS) issued a joint warning about the healthcare industry being a target of expanding ransomware activity. Meanwhile, ransom financial demands are rising and adversaries are resorting to increasingly brazen methods, including exfiltrating data and extorting patients. COVID-19 has accelerated the trend toward connectivity in healthcare. We have added remote workers and remote patients using telehealth services and are placing devices in patients’ homes, offering a wide range of attack opportunities as critical data are transmitted across home and public networks. Healthcare is now taking place in a much more complex and highly accessible space, offering rich data and a growing attack surface. With the rapidly evolving, increasingly connected information technology (IT) infrastructure and growth of cyberthreats, healthcare is facing a perfect storm. The danger is exacerbated by the fact that we are no longer dealing solely with individual hackers but mainly with well-resourced cybercriminal organizations, as well as politically and economically motivated adversaries (e.g., nation-states, cyber terrorists). Global economic losses due to cyber incidents are estimated to be in the $3-trillion range and are expected to reach $6 trillion in 2021 and $10.5 trillion by 2025. Healthcare organizations are expected to spend $125 billion on cybersecurity over the next 5 years. It is imperative that healthcare improve its cyber defenses and “cyber culture.” This includes expanding our understanding of cyber risks, better defining what we must protect, learning how to protect it in ways that support efficient workflows and safety, and instilling good user cyber behavior. IT security and clinical engineering cannot do this alone. To develop a safe and effective path forward, we also need cyber-savvy clinicians working as partners to ensure that clinical needs are met in security decisions. This article proposes an approach and explores how we might achieve this.
{"title":"Balancing Patient Safety, Clinical Efficacy, and Cybersecurity with Clinician Partners.","authors":"Joseph Schneider,&nbsp;Axel Wirth","doi":"10.2345/0899-8205-55.1.21","DOIUrl":"https://doi.org/10.2345/0899-8205-55.1.21","url":null,"abstract":"Where We Stand Today Cybersecurity events affecting healthcare organizations are in the news with increasing frequency, indicating their growing impact and expanse. We have seen incidents ranging from breaches affecting millions of patient records to attacks shutting down hospitals across the country, with at least one of them tragically contributing to the death of a patient. Most recently, the Cybersecurity and Infrastructure Security Agency, Federal Bureau of Investigation, and Department of Health & Human Services (HHS) issued a joint warning about the healthcare industry being a target of expanding ransomware activity. Meanwhile, ransom financial demands are rising and adversaries are resorting to increasingly brazen methods, including exfiltrating data and extorting patients. COVID-19 has accelerated the trend toward connectivity in healthcare. We have added remote workers and remote patients using telehealth services and are placing devices in patients’ homes, offering a wide range of attack opportunities as critical data are transmitted across home and public networks. Healthcare is now taking place in a much more complex and highly accessible space, offering rich data and a growing attack surface. With the rapidly evolving, increasingly connected information technology (IT) infrastructure and growth of cyberthreats, healthcare is facing a perfect storm. The danger is exacerbated by the fact that we are no longer dealing solely with individual hackers but mainly with well-resourced cybercriminal organizations, as well as politically and economically motivated adversaries (e.g., nation-states, cyber terrorists). Global economic losses due to cyber incidents are estimated to be in the $3-trillion range and are expected to reach $6 trillion in 2021 and $10.5 trillion by 2025. Healthcare organizations are expected to spend $125 billion on cybersecurity over the next 5 years. It is imperative that healthcare improve its cyber defenses and “cyber culture.” This includes expanding our understanding of cyber risks, better defining what we must protect, learning how to protect it in ways that support efficient workflows and safety, and instilling good user cyber behavior. IT security and clinical engineering cannot do this alone. To develop a safe and effective path forward, we also need cyber-savvy clinicians working as partners to ensure that clinical needs are met in security decisions. This article proposes an approach and explores how we might achieve this.","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"55 1","pages":"21-28"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641426/pdf/i0899-8205-55-1-21.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25335624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Even the Simplest Devices May Malfunction: Split Septum Design Revisited. 即使是最简单的设备也可能出现故障:重新审视分隔设计。
Q4 Medicine Pub Date : 2021-01-01 DOI: 10.2345/0890-8205-55.1.41
R. Naftalovich, S. Char, Andrew Iskander, D. Naftalovich
Split septum medical devices are used in tubing for intravenous (IV) fluid administration-an extremely common clinical task. These tubing caps contain a needleless, valveless system that allows fluid to flow directly through the lumen of the catheter but prevents backflow of fluid or blood when the tubing extension is not connected. We experienced complete failure of a needle-free connector extension set with a Luer-access split septum device in multiple patients due to the split septum remaining fused and essentially unsplit despite being connected on both ends. This led to an adverse event in a patient due to repeated unnecessary IV insertion attempts. This case shows how even the simplest of devices can malfunction and highlights the need for vigilance in clinical practice.
分离隔膜医疗设备用于静脉(IV)液体给药的管道中,这是一项极其常见的临床任务。这些管帽包含无针、无阀系统,该系统允许流体直接流过导管的管腔,但在未连接管延伸部时防止流体或血液回流。我们在多例患者中经历了带有Luer access分裂隔膜装置的无针连接器扩展套件的完全失败,因为尽管两端连接,但分裂隔膜仍保持融合且基本上未分裂。由于反复进行不必要的静脉注射,导致患者出现不良事件。这个案例表明,即使是最简单的设备也会出现故障,并强调了临床实践中保持警惕的必要性。
{"title":"Even the Simplest Devices May Malfunction: Split Septum Design Revisited.","authors":"R. Naftalovich, S. Char, Andrew Iskander, D. Naftalovich","doi":"10.2345/0890-8205-55.1.41","DOIUrl":"https://doi.org/10.2345/0890-8205-55.1.41","url":null,"abstract":"Split septum medical devices are used in tubing for intravenous (IV) fluid administration-an extremely common clinical task. These tubing caps contain a needleless, valveless system that allows fluid to flow directly through the lumen of the catheter but prevents backflow of fluid or blood when the tubing extension is not connected. We experienced complete failure of a needle-free connector extension set with a Luer-access split septum device in multiple patients due to the split septum remaining fused and essentially unsplit despite being connected on both ends. This led to an adverse event in a patient due to repeated unnecessary IV insertion attempts. This case shows how even the simplest of devices can malfunction and highlights the need for vigilance in clinical practice.","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"55 1 1","pages":"41-43"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43279393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Even the Simplest Devices May Malfunction: Split Septum Design Revisited. 即使是最简单的设备也可能出现故障:重新审视分隔设计。
Q4 Medicine Pub Date : 2021-01-01 DOI: 10.2345/0899-8205-55.1.41
Rotem Naftalovich, Steven Char, Andrew J Iskander, Daniel Naftalovich

Split septum medical devices are used in tubing for intravenous (IV) fluid administration-an extremely common clinical task. These tubing caps contain a needleless, valveless system that allows fluid to flow directly through the lumen of the catheter but prevents backflow of fluid or blood when the tubing extension is not connected. We experienced complete failure of a needle-free connector extension set with a Luer-access split septum device in multiple patients due to the split septum remaining fused and essentially unsplit despite being connected on both ends. This led to an adverse event in a patient due to repeated unnecessary IV insertion attempts. This case shows how even the simplest of devices can malfunction and highlights the need for vigilance in clinical practice.

分隔医疗设备用于静脉注射(IV)液体管理的管道,这是一项极其常见的临床任务。这些管帽包含一个无针、无阀系统,允许液体直接流过导管的管腔,但防止液体或血液回流,当管道延伸不连接。我们在多例患者中经历了无针连接器延长装置与luer通路分离隔膜装置的完全失败,原因是尽管分离隔膜两端连接,但仍然融合且基本上未分裂。由于多次不必要的静脉注射尝试,这导致了患者的不良事件。这个案例表明,即使是最简单的设备也可能出现故障,并强调了在临床实践中保持警惕的必要性。
{"title":"Even the Simplest Devices May Malfunction: Split Septum Design Revisited.","authors":"Rotem Naftalovich,&nbsp;Steven Char,&nbsp;Andrew J Iskander,&nbsp;Daniel Naftalovich","doi":"10.2345/0899-8205-55.1.41","DOIUrl":"https://doi.org/10.2345/0899-8205-55.1.41","url":null,"abstract":"<p><p>Split septum medical devices are used in tubing for intravenous (IV) fluid administration-an extremely common clinical task. These tubing caps contain a needleless, valveless system that allows fluid to flow directly through the lumen of the catheter but prevents backflow of fluid or blood when the tubing extension is not connected. We experienced complete failure of a needle-free connector extension set with a Luer-access split septum device in multiple patients due to the split septum remaining fused and essentially unsplit despite being connected on both ends. This led to an adverse event in a patient due to repeated unnecessary IV insertion attempts. This case shows how even the simplest of devices can malfunction and highlights the need for vigilance in clinical practice.</p>","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"55 1","pages":"41-43"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641422/pdf/i0899-8205-55-1-41.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25453724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reading Room: Reading Room. 阅览室:阅览室。
Q4 Medicine Pub Date : 2020-11-01 DOI: 10.2345/0899-8205-54.6.450
Nathan Lynch
{"title":"Reading Room: Reading Room.","authors":"Nathan Lynch","doi":"10.2345/0899-8205-54.6.450","DOIUrl":"https://doi.org/10.2345/0899-8205-54.6.450","url":null,"abstract":"","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"54 6","pages":"450"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38730648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bright Ideas: Picturing a Future for Diagnostic Imaging Apprentices. 光明的想法:描绘诊断成像学徒的未来。
Q4 Medicine Pub Date : 2020-11-01 DOI: 10.2345/0899-8205-54.6.434
Brian Stallard
{"title":"Bright Ideas: Picturing a Future for Diagnostic Imaging Apprentices.","authors":"Brian Stallard","doi":"10.2345/0899-8205-54.6.434","DOIUrl":"https://doi.org/10.2345/0899-8205-54.6.434","url":null,"abstract":"","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"54 6","pages":"434-437"},"PeriodicalIF":0.0,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38730647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomedical Instrumentation and Technology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1